Stanford School of Medicine
Urology

Donna Peehl

Email:
Profile: http://med.stanford.edu/profiles/Donna_Peehl/
Academic Appointments
Appointment
Organization
Professor (Research)
Member
Member
Graduate & Fellowship Program Affiliations
 
Honors & Awards
Title
Organization
Date(s)
Cardura International Competitive Award
Pfizer
2000/2001
Prostate Cancer Research Award
Prostate Cancer Foundation
2003
Prostate Cancer Research Award
CaP CURE
1993,1995,1996,1997,1999,2000
Professional Education
Degree
Awarding Institution
Field of Study
Year of Graduation
Ph.D.
University of Colorado
biology
1979
Postdoctoral Advisees
Vincent Flamand
Web Site Links
Research/Lab website:   urology site
Research Interests

Prostate cancer and benign prostatic hyperplasia (BPH) are major medical problems. We have developed techniques with which we can establish primary cultures of epithelial or stromal cells from normal, BPH or malignant prostatic tissues. We have used these cultures to investigate many aspects of molecular and cellular biology of the prostate. Our overall goal is to characterize growth regulatory processes that occur in the normal prostate, then to identify aberrations that may occur in cancer or BPH. With this knowledge, we may develop new approaches for prevention,diagnosis or therapy of prostate cancer or BPH. One growth-regulatory factor of current interest in our laboratory is vitamin D. Our studies with prostatic cell cultures have shown that prostate cells have vitamin D receptors and are targets of growth-inhibitory and differentiating activities of vitamin D. Our pre-clinical studies have led to pilot clinical studies to explore the efficacy of vitamin D as a therapeutic agent against prostate cancer. Techniques used in our laboratory include cell culture of primary tissues in serum-free medium, three-dimensional cultures, tissue slice cultures, immunochemistry, immunoblots, and transfection.

Publications
  • Zhao H, Nolley R, Chen Z, Reese SW, Peehl DM "Inhibition of monoamine oxidase A promotes secretory differentiation in basal prostatic epithelial cells." Differentiation 2008; More »
  • Swami S, Krishnan AV, Moreno J, Bhattacharyya RB, Peehl DM, Feldman D "Calcitriol and genistein actions to inhibit the prostaglandin pathway: potential combination therapy to treat prostate cancer." J Nutr 2007; 137: 1: 205S-10S More »
  • Krishnan AV, Moreno J, Nonn L, Malloy P, Swami S, Peng L, Peehl DM, Feldman D "Novel pathways that contribute to the anti-proliferative and chemopreventive activities of calcitriol in prostate cancer." J Steroid Biochem Mol Biol 2007; More »
  • Krishnan AV, Swami S, Moreno J, Bhattacharyya RB, Peehl DM, Feldman D "Potentiation of the growth-inhibitory effects of vitamin D in prostate cancer by genistein." Nutr Rev 2007; 65: 8 Pt 2: S121-3 More »
  • Feldman D, Krishnan A, Moreno J, Swami S, Peehl DM, Srinivas S "Vitamin D inhibition of the prostaglandin pathway as therapy for prostate cancer." Nutr Rev 2007; 65: 8 Pt 2: S113-5 More »
86 publications:   view full list

Institution Links:

Footer Links: